OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

OraSure Technologies, Inc. (NASDAQ:OSUR) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.50 and traded as high as $3.86. OraSure Technologies shares last traded at $3.70, with a volume of 419,125 shares traded.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Wall Street Zen upgraded shares of OraSure Technologies from a “sell” rating to a “hold” rating in a report on Monday, August 10th. Weiss Ratings raised shares of OraSure Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, OraSure Technologies presently has a consensus rating of “Reduce” and an average price target of $3.00.

OraSure Technologies Price Performance

The stock’s 50 day simple moving average is $4.12 and its two-hundred day simple moving average is $3.50. The stock has a market capitalization of $267.60 million, a PE ratio of -5.62 and a beta of 1.00.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of OSUR. Quadrature Capital Ltd purchased a new position in OraSure Technologies in the 4th quarter worth approximately $28,000. Legal & General Group Plc purchased a new stake in shares of OraSure Technologies during the 2nd quarter valued at $30,000. Prudential Financial Inc. bought a new stake in shares of OraSure Technologies during the 2nd quarter worth $31,000. Diversify Wealth Management LLC bought a new stake in shares of OraSure Technologies during the 1st quarter worth $36,000. Finally, Diversify Advisory Services LLC purchased a new position in OraSure Technologies in the second quarter worth $47,000. 93.50% of the stock is owned by institutional investors.

About OraSure Technologies

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.